Vandana Luthra
Biostatistics in development of Medical Devices By T. Mudde - Clinquest (Qserve Conference 2013)
Clinical evaluations and impact of the new Regulations y R. Higgins MHRA ( Qserve Conference 2013)
Potential effects of the upcoming Regulations By Dr. J O’ Dwyer -NSAI (Qserve conference 2013)
Risk-based Monitoring Strategies for Improved Clinical Trial Performance
Toxicology Tutor 2008
FDA GUIDANCE: Oversight Of Clinical Investigations Risk Based Approach To Monitoring Draft 1108
Noninvasive Face Mask Ventilation
(1) Chapter 9 - Jose Rizal in Berlin, Germany (B)
Distal gastrectomy with B1, B2 anastomsis or Roux-En-Y Jeffrey A. Neale MD 1/31/08.
Compliance Considerations in Pharmaceutical Product Development Compliance Considerations in Pharmaceutical Product Development John C. (Jack) Garvey,
A History of Stats at the FDA Mary A. Foulkes, Ph.D. U.S. Food And Drug Administration Office of Biostatistics and Epidemiology Center for Biologics Evaluation.
